Multiple Myeloma Mechanism of Action

Pharmacology of Carmustine (Bicnu) ; Overview, Pharmacokinetics, Mechanism of action, Uses, EffectsПодробнее

Pharmacology of Carmustine (Bicnu) ; Overview, Pharmacokinetics, Mechanism of action, Uses, Effects

Selinexor in the treatment of R/R myeloma: combination strategies and optimizing therapyПодробнее

Selinexor in the treatment of R/R myeloma: combination strategies and optimizing therapy

Sequencing CAR T-cells and bispecific antibodies in the treatment of multiple myelomaПодробнее

Sequencing CAR T-cells and bispecific antibodies in the treatment of multiple myeloma

Overcoming T-cell exhaustion to improve CAR-T efficacy in multiple myelomaПодробнее

Overcoming T-cell exhaustion to improve CAR-T efficacy in multiple myeloma

Immune strategies in consolidation and maintenance for multiple myelomaПодробнее

Immune strategies in consolidation and maintenance for multiple myeloma

Bispecific Antibodies in MyelomaПодробнее

Bispecific Antibodies in Myeloma

Selinexor in the myeloma treatment landscape and managing associated side effectsПодробнее

Selinexor in the myeloma treatment landscape and managing associated side effects

How does selinexor fit into the treatment algorithm for myeloma?Подробнее

How does selinexor fit into the treatment algorithm for myeloma?

Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024Подробнее

Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024

An Update on the Use of Bispecific Antibodies in Myeloma | Mohamad Mohty, MD | IMS 2024Подробнее

An Update on the Use of Bispecific Antibodies in Myeloma | Mohamad Mohty, MD | IMS 2024

Triplet regimens for treating multiple myeloma at early relapseПодробнее

Triplet regimens for treating multiple myeloma at early relapse

Dr Krishnan on the Evolving Role of Belantamab Mafodotin in Multiple MyelomaПодробнее

Dr Krishnan on the Evolving Role of Belantamab Mafodotin in Multiple Myeloma

Symposium | Next wave of immune-based therapies: What you need to know, which focused on R/R MMПодробнее

Symposium | Next wave of immune-based therapies: What you need to know, which focused on R/R MM

The evolving use of selinexor in multiple myelomaПодробнее

The evolving use of selinexor in multiple myeloma

Darzalex (daratumumab) - 2024 Updated #myelomaПодробнее

Darzalex (daratumumab) - 2024 Updated #myeloma

Relapsed/refractory multiple myeloma (RRMM): The relevance of adding a new MoAПодробнее

Relapsed/refractory multiple myeloma (RRMM): The relevance of adding a new MoA

Symposium | How to sequence CAR T-cell therapy and bispecific antibodies in R/R multiple myelomaПодробнее

Symposium | How to sequence CAR T-cell therapy and bispecific antibodies in R/R multiple myeloma

Dexamethasone - Uses, Mechanism Of Action, Pharmacology, Adverse Effects & ContraindicationsПодробнее

Dexamethasone - Uses, Mechanism Of Action, Pharmacology, Adverse Effects & Contraindications

Multiple Myeloma: Unmet medical needs in early relapseПодробнее

Multiple Myeloma: Unmet medical needs in early relapse

Relapsed/refractory multiple myeloma (RRMM): Best practices in treating early RRMMПодробнее

Relapsed/refractory multiple myeloma (RRMM): Best practices in treating early RRMM